1[1]National committee for clinical laboratory standards reference method for broth dilution antifungal susceptibility testing of yeast: approved Standard M27-A[J]. National Committee for Clinical Laboratory Standards Villanova Pa, 1997.6.
2[2]Oscar M, Philippe M, Michel PG, et al. Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans[J ]. Antimicrobial Agents and Chemotheraphy, 2000,44; 2373 - 2381.
3[3]Ryder NS. Activity of terbinafine against serious fungal pathogens[J].Mycoses, 1999,42 (Suppl) :2115 - 2119.
4[4]Ryder NS, Leitner I. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species[J ]. Med-Mycol, 2001,39(1):91-95.
5[5]Barchiesi F, Di-Francesco LF, Compagnucci P, et al. In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans[J ]. J Antimicrob Chemother,1998,41(1): 59-65.
6[6]Ghannoum MA, Elewski B. Successful treatment of fluconazole-resistant oropharyngeal candidiasis by a combination of fluconazole and terbinafine[J ]. Clin Diagn Lab Immunol, 1999,6(6) :921 - 923.
7[7]Shenep JL, English BK,Kaufman L, et al. Successful medical therapy for deeply invasive facial infection due to Pythium insidiosum in a child [J]. Clin Infect Dis, 1998,27(6): 1388 - 1393.
8[8]Gupta AK, Lynde CW, Konnikov N, et al. Single-blind, randomized,prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis [J] .J Am Acad Dermatol, 2001,44(3) :485 - 491.
3Jessup CJ,Warner J,Isham N,et al.Antifungal susceptibility testing of dermatophytes:establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates.J Clin Microbiol,2000,38(1):341-344.
4de Hoog GS,Guarro J,Gene J,et al.Atlas of Clinical Fungi.2nd edition.Utrecht,the Netherlands:Centraalbureau voor Schimmelcultures / Reus Spain:Universitat Rovira Ⅰ Virgili,2000:361-1007.
